Antom, Ant International’s merchant payment and digitisation services provider, today announced a major upgrade to its flagship AI agent, Antom Copilot, with expanded capabilities across payment integration, onboarding, risk configuration, and chargeback solution. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250717902855/en/Antom Copilot 2.0 equips merchants with AI-powered chargeback management and win-rate predictions through an...

Innospera Pharma Inc. (“Innospera”), a private, near-clinical-stage biotechnology company advancing differentiated small molecule modulators of GPR84 and GPR40 to treat inflammatory and metabolic diseases, today announced the appointment of Dr. Glenn Crater, MD, FCCP as Chief Medical Officer (CMO). Glenn will start immediately as a fractional CMO, with the commitment to joining full time as the Company’s lead compound reaches the clinic. This press release features multimedia. View the full re...